4.7 Article Proceedings Paper

Functional defect in regulatory T cells in myasthenia gravis

Journal

MYASTHENIA GRAVIS AND RELATED DISORDERS I
Volume 1274, Issue -, Pages 68-76

Publisher

BLACKWELL SCIENCE PUBL
DOI: 10.1111/j.1749-6632.2012.06840.x

Keywords

myasthenia gravis; regulatory T cells; FOXP3; GM-CSF

Funding

  1. NIH (National Institute of Neurologic Disorders and Stroke [K08NS058800]
  2. National Institute of Allergy and Infectious Diseases [RO1 AI 058190]
  3. Muscular Dystrophy Association [MDA 185924, MDA 157286]
  4. University of Illinois at Chicago (UIC) Center for Clinical and Translational Science (CCTS)
  5. National Center for Research Resources [UL1RR029879]

Ask authors/readers for more resources

Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T cells (T-reg cells). T-reg cells maintain immune homeostasis and self-tolerance and play an important role in the prevention of autoimmune disease. Here, we discuss the role of T-reg cells in the pathogenesis of myasthenia gravis (MG) and review evidence indicating that a significant defect in T-reg cell in vitro suppressive function exists in MG patients, without an alteration in circulating frequency. This functional defect is associated with a reduced expression of key functional molecules, such as FOXP3 on isolated T-reg cells, and appears to be more pronounced in immunosuppression-naive MG patients. In vitro administration of granulocyte macrophage-colony-stimulating factor (GM-CSF) enhanced the suppressive function of T-reg cells and upregulated FOXP3 expression. These findings indicate a clinically relevant T-reg cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available